Clinical MS Research Group
Our single objective: to prevent and reverse disability for everyone with multiple sclerosis, neuromyelitis optica and MOG associated disease.
Research Themes
Cambridge Clinical Multiple Sclerosis Research Group is achieving this objective through six themes:
​
-
Personalising Treatments through Big Data and AI
-
Discovering and Proving New Repair therapies
-
Our Visual and MRI Outcome Development Program
-
Studying Children with MS, NMO and related conditions
-
Study ageing in multiple sclerosis
-
Measuring and sustainably addressing healthcare inequalities.
Currently our work is focused on:
-
Improving the availability of data in electonic health records in the UK for MS researchers
-
Using real-world data to answer important questions about how best to use MS therapies
-
Exploring how best to measure remyelination in adults and children with MS
-
Investigating natural remyelination in people with MS
-
Doing clinical trials to identify drugs which promote endogenous remyelination in people with MS
​​
Read more here.
Featured News
CCMR Two Results Presented at ECTRIMS 2025
​
26th September 2025
Nicholas Cunniffe had the honour of presenting during the prestigious Late Breaking Abstracts session at ECTRIMS 2025. His talk presented the headline results from our CCMR Two trial, the third study to demonstrate that remyelination is possible in people living with multiple sclerosis.
Read more here.
​
Building Connections, Advancing Research: Reflecting on ECTRIMS 2025
26th September 2025
As ECTRIMS 2025 concludes, we are thrilled to report that it has been another successful Congress for our entire team.
Read more here.
Personalised Treatment Team Member Receives ACT Fellowship!
28th July 2025
We are delighted to share that Daniela Soares Régua, a multiple sclerosis nurse specialist, has been awarded an ACT Fellowship and will be embarking on a PhD within the Multiple Sclerosis Personalised Treatment Group at the University of Cambridge.
Read more here.​​
​